Thrombin-receptor activation and thrombin-induced brain tolerance
about
The Importance of Thrombin in Cerebral Injury and DiseaseIntercellular cross-talk in intracerebral hemorrhageBrain alpha- and beta-globin expression after intracerebral hemorrhage.Thrombin-induced neuronal protection: role of the mitogen activated protein kinase/ribosomal protein S6 kinase pathway.Pharmacologic preconditioning: translating the promiseProgressing haemorrhagic stroke: categories, causes, mechanisms and managements.Thrombin signaling in the brain: the role of protease-activated receptors.Expression, sorting and transport studies for the orphan carrier SLC10A4 in neuronal and non-neuronal cell lines and in Xenopus laevis oocytes.Ischaemic preconditioning: therapeutic implications for stroke?Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.Effect of iron chelators on methemoglobin and thrombin preconditioningMinocycline reduces intracerebral hemorrhage-induced brain injury.Endogenous protease nexin-1 protects against cerebral ischemia.Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function.Effects of cerebral ischemia on neuronal hemoglobinThe effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury.Intracerebral haemorrhage: mechanisms of injury and therapeutic targets.Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhageHomeostatic effects of coagulation protease-dependent signaling and protease activated receptors.Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells.Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats.PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia.Chronic LiCl pretreatment suppresses thrombin-stimulated intracellular calcium mobilization through TRPC3 in astroglioma cells.Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron.CD163 Expression in Neurons After Experimental Intracerebral Hemorrhage.Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation.
P2860
Q26772131-65743C62-3895-4236-AA92-FCFB7F2B8356Q27692109-C10A1E36-B8FC-4620-9EDB-F77214FED94DQ33921060-3F3C7E21-5A16-47B1-B33E-B05D62AB938AQ34238634-32D33A3B-58FA-4B06-B201-4A6E2E0094F1Q34440453-81DCBBFF-1DEB-4C09-8363-9B11DF9971DCQ34459723-0D0ABC9D-582B-49D6-B3D7-E36883AF298DQ35098769-CFB2F6BF-7CBF-454E-A0C5-83F3B1C86851Q35666540-DC59A8C8-5C83-40B6-B2C5-7AB41CDA92FFQ35753366-96E64083-C316-4564-A33B-420D96F7451DQ36380440-1899135D-8B83-45FD-B3E9-A1F113156C2EQ36757460-BD1D7AF7-A724-4ED8-8130-19F662F43D2EQ37137083-410837BC-62B5-4FCF-9D9D-9B9445F8A7FBQ37139215-F0631728-C35A-4EBA-B32C-46C302E459FFQ37186180-509D63B8-8778-40BE-B0C7-AEB36366D8C8Q37195575-31108A07-6B4E-4DE0-BAC2-B305C3D819ACQ37216287-CDECE676-1D06-4F12-B040-772E240849C5Q37217423-2A5C1D90-18ED-4631-9946-106FA5BC0450Q37337439-0953D3B7-5166-4C78-9BC7-FACB4B5BB193Q37448194-EE665040-5194-4E2B-AB2B-F8BFE75F1455Q39268424-CA400D7F-3AAE-4516-881D-5D2E3C3A1860Q39410950-6BB2D8F0-8289-4ACE-9A56-D0643D7A2C0CQ39658447-EC3507C2-A4A7-4863-9303-42540527AFC9Q42463329-87E2669D-54CC-465B-A199-E5286276047EQ42482446-33A4B2EC-7766-4D19-B534-F17C507D9A51Q45050935-A9003E5E-8E2B-405F-8C24-3EDE59B848B7Q47872081-65BC08E7-17F2-4DC2-A06F-4A66514287C0Q48121667-47FBDD3C-2F15-47EB-9BD5-F1A3E286A669Q48237746-DE466730-B56A-46B0-9304-E19873FE0A3CQ48622856-11A6A188-DA05-42BB-8597-E0462834B717
P2860
Thrombin-receptor activation and thrombin-induced brain tolerance
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/04/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/04/01)
@nl
наукова стаття, опублікована у квітні 2002
@uk
مقالة علمية نشرت في أبريل 2002 حول موضوع: دماغ
@ar
name
Thrombin-receptor activation and thrombin-induced brain tolerance
@ast
Thrombin-receptor activation and thrombin-induced brain tolerance
@en
Thrombin-receptor activation and thrombin-induced brain tolerance
@nl
type
label
Thrombin-receptor activation and thrombin-induced brain tolerance
@ast
Thrombin-receptor activation and thrombin-induced brain tolerance
@en
Thrombin-receptor activation and thrombin-induced brain tolerance
@nl
prefLabel
Thrombin-receptor activation and thrombin-induced brain tolerance
@ast
Thrombin-receptor activation and thrombin-induced brain tolerance
@en
Thrombin-receptor activation and thrombin-induced brain tolerance
@nl
P2093
P2860
P1476
Thrombin-receptor activation and thrombin-induced brain tolerance
@en
P2093
Jianming Xiang
Julian T. Hoff
Richard F. Keep
Yajun Jiang
P2860
P304
P356
10.1097/00004647-200204000-00004
P577
2002-04-01T00:00:00Z
P5875
P6179
1028228087